峰瑞资本
@author-1781068851320
507 articles
Articles
FreeS Fund Report 15: The Life Gamble — The Risk-Filled Journey of Drug R&D | Frees Fund
The Ideals and Persistence Behind a 3% Success Rate.
XtalPi Closes $46 Million Series B+ Round | FreeS Fund Deal Brief
Empowering drug R&D organizations worldwide.
FreeS Fund Angel-Round Portfolio Company NextVPU Closes 200 Million RMB Series A | FreeS Funding News
We provide professional solutions for robotics, drones, autonomous vehicles, and security surveillance.
Another New Retail Unicorn Emerges: FreeS Fund Angel-Round Project Huasheng Haoche Closes $210M Series B | FreeS Funding News
FreeS Fund continued to increase its stake.
Li Feng's Column 13: China Is at Its Most Precious Historical Moment | Frees Fund
Over four decades of turbulence, the darkest days have always given rise to market opportunities.
FreeS Fund II Completes First Close, New Launches, Awards... 13 Updates and 4 Insights | FreeS Fund Blackboard · September
Stay grounded, keep pushing forward.
Li Feng Column 12: A Speculation on the Endgame of China's New Retail | Frees Fund
Short-term: traffic. Medium-term: efficiency. Long-term: supply chain.
Li Feng Column 11: The Middle Path for New Retail | Frees Fund
The Three Axes of Understanding New Retail
Top 5/15/50/100, Going Global to India, Teaming Up with Tencent on IVI... 13 Takeaways and 8 Insights | FreeS Chalkboard · August
"Choose the more long-term path, even if it's the harder one."
From One Person to 1,000: How to Find and Hire People Through Every Painful Transformation | FreeS Talk
150 people is a tipping point. It's the most dangerous moment, when company culture gets diluted and washed out.